10-K/A Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 FY 2016

Filing Information

Form Type	10-K/A
Accession Number	`0001079974-17-000131`
Period End Date	20161231
Filing Date	20170404
Fiscal Year	2016
Fiscal Period	FY
XBRL Instance	amhi-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 51 Cash Flow Statement 51 Stockholders Equity 22

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	363,611.00	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	363,611.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$4.87M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$8.06M	USD	Point-in-time
Investments	`Investments`	$82.91K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Investments	`Investments`	$82.91K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$343.81K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$542.24K	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	13.89M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.06M	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	11.87M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	33,333.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$73.07K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	13.89M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$100.24K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	11.87M	shares	Point-in-time
Intangible assets - net	`FiniteLivedIntangibleAssetsNet`	$8.76M	USD	Point-in-time
Intangible assets - net	`FiniteLivedIntangibleAssetsNet`	$3.11M	USD	Point-in-time
Acquired goodwill	`Goodwill`	$17.09M	USD	Point-in-time
Acquired goodwill	`Goodwill`	$3.47M	USD	Point-in-time
Deferred income tax assets, net	`DeferredIncomeTaxAssetsNet`	-	USD	Point-in-time
Deferred income tax assets, net	`DeferredIncomeTaxAssetsNet`	$3.49M	USD	Point-in-time
Total other assets	`OtherAssets`	$6.66M	USD	Point-in-time
Total other assets	`OtherAssets`	$29.44M	USD	Point-in-time
Total Assets	`Assets`	$39.51M	USD	Point-in-time
Total Assets	`Assets`	$13.83M	USD	Point-in-time
Line of credit	`ShorttermDebtFairValue`	$1.24M	USD	Point-in-time
Line of credit	`ShorttermDebtFairValue`	$3.09M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.13M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.60M	USD	Point-in-time
Other accrued expenses	`OtherLiabilitiesCurrent`	$1.09M	USD	Point-in-time
Other accrued expenses	`OtherLiabilitiesCurrent`	$2.17M	USD	Point-in-time
Current Portion - Long Term Notes	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Current Portion - Long Term Notes	`LongTermDebtNoncurrent`	$405.38K	USD	Point-in-time
Consideration payable - Cash	`CededPremiumsPayable`	$1.85M	USD	Point-in-time
Consideration payable - Cash	`CededPremiumsPayable`	$3.65M	USD	Point-in-time
Consideration payable - Equity	`ConsiderationPayableEquity`	$-64.38K	USD	Point-in-time
Consideration payable - Equity	`ConsiderationPayableEquity`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.71M	USD	Point-in-time
Convertible notes	`ConvertibleLongTermNotesPayable`	$5.00M	USD	Point-in-time
Convertible notes	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Long-term notes - Net of Current Portion	`LongTermDebtCurrent`	-	USD	Point-in-time
Long-term notes - Net of Current Portion	`LongTermDebtCurrent`	$1.54M	USD	Point-in-time
Long-term consideration payable - Cash	`LongtermConsiderationPayableCash`	-	USD	Point-in-time
Long-term consideration payable - Cash	`LongtermConsiderationPayableCash`	$2.71M	USD	Point-in-time
Long-term consideration payable - Equity	`LongtermConsiderationPayableEquity`	-	USD	Point-in-time
Long-term consideration payable - Equity	`LongtermConsiderationPayableEquity`	$10.89M	USD	Point-in-time
Total Long-term Liabilities	`LiabilitiesNoncurrent`	$5.00M	USD	Point-in-time
Total Long-term Liabilities	`LiabilitiesNoncurrent`	$15.14M	USD	Point-in-time
Total liabilities	`Liabilities`	$27.84M	USD	Point-in-time
Total liabilities	`Liabilities`	$13.58M	USD	Point-in-time
Preferred stock, $0.01 par value; 1,000,000 authorized, 363,611 issued and outstanding as of December 31, 2016, and none outstanding as of December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; 1,000,000 authorized, 363,611 issued and outstanding as of December 31, 2016, and none outstanding as of December 31, 2015	`PreferredStockValue`	$3.64K	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 13,885,972 and 11,874,361 issued and outstanding as of December 31, 2016, and December 31, 2015, respectively	`CommonStockValue`	$138.86K	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 13,885,972 and 11,874,361 issued and outstanding as of December 31, 2016, and December 31, 2015, respectively	`CommonStockValue`	$118.74K	USD	Point-in-time
Additional paid-In capital	`AdditionalPaidInCapitalCommonStock`	$1.19M	USD	Point-in-time
Additional paid-In capital	`AdditionalPaidInCapitalCommonStock`	$15.36M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.05M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities`	-	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities`	$7.43K	USD	Point-in-time
Non-Controlling Interest	`MinorityInterest`	-	USD	Point-in-time
Non-Controlling Interest	`MinorityInterest`	$3.38K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$972.86K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$258.53K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.66M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$39.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.83M	USD	Point-in-time

Income Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`Revenues`	$20.26M	USD	Annual
Net revenue	`Revenues`	$36.15M	USD	Annual
Cost of revenue	`CostOfRevenue`	$13.39M	USD	Annual
Cost of revenue	`CostOfRevenue`	$29.61M	USD	Annual
Gross profit	`GrossProfit`	$6.54M	USD	Annual
Gross profit	`GrossProfit`	$6.87M	USD	Annual
Selling and marketing	`SellingAndMarketingExpense`	$119.85K	USD	Annual
Selling and marketing	`SellingAndMarketingExpense`	$417.25K	USD	Annual
General and administration	`GeneralAndAdministrativeExpense`	$5.72M	USD	Annual
General and administration	`GeneralAndAdministrativeExpense`	$8.55M	USD	Annual
Nonrecurring expenditures	`PaymentsForMergerRelatedCosts`	$-1.59M	USD	Annual
Nonrecurring expenditures	`PaymentsForMergerRelatedCosts`	$-1.66M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$166.21K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.36M	USD	Annual
Operating expenses	`OperatingExpenses`	$7.66M	USD	Annual
Operating expenses	`OperatingExpenses`	$11.92M	USD	Annual
Operating income (loss):	`OperatingIncomeLoss`	$-793.98K	USD	Annual
Operating income (loss):	`OperatingIncomeLoss`	$-5.38M	USD	Annual
Interest expense	`InterestExpense`	$751.07K	USD	Annual
Interest expense	`InterestExpense`	$238.47K	USD	Annual
Interest income/other income	`InterestIncomeExpenseNet`	$89.92K	USD	Annual
Interest income/other income	`InterestIncomeExpenseNet`	-	USD	Annual
Other income	`OtherIncome`	$16.60K	USD	Annual
Other income	`OtherIncome`	-	USD	Annual
Change due to estimate correction	`ChangeDueToEstimateCorrection`	$-410.82K	USD	Annual
Change due to estimate correction	`ChangeDueToEstimateCorrection`	-	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-1.15M	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-148.55K	USD	Annual
Net income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-6.53M	USD	Annual
Net income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-942.53K	USD	Annual
Income tax benefit (provision)	`IncomeTaxExpenseBenefit`	$-128.46K	USD	Annual
Income tax benefit (provision)	`IncomeTaxExpenseBenefit`	$-3.75M	USD	Annual
Net income (loss)	`ProfitLoss`	$-814.08K	USD	Annual
Net income (loss)	`ProfitLoss`	$-2.78M	USD	Annual
Non-controlling interest	`IncomeLossAttributableToNoncontrollingInterest`	$-3.38K	USD	Annual
Non-controlling interest	`IncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net income (loss) attributable to the Company	`NetIncomeLoss`	$-1.89M	USD	3 Qtrs
Net income (loss) attributable to the Company	`NetIncomeLoss`	$-2.78M	USD	Annual
Net income (loss) attributable to the Company	`NetIncomeLoss`	$-814.08K	USD	Annual
Foreign exchange translation adjustment	`ForeignCurrencyTransactionGainLossBeforeTax`	$-7.43K	USD	Annual
Foreign exchange translation adjustment	`ForeignCurrencyTransactionGainLossBeforeTax`	-	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-814.08K	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.79M	USD	Annual
Basic income (loss) per share	`EarningsPerShareBasic`	$-0.07	USD	Annual
Basic income (loss) per share	`EarningsPerShareBasic`	$-0.21	USD	Annual
Diluted income (loss) per share	`EarningsPerShareDiluted`	$-0.07	USD	Annual
Diluted income (loss) per share	`EarningsPerShareDiluted`	$-0.21	USD	Annual
Basic weighted average number of shares	`WeightedAverageNumberOfSharesOutstandingBasic`	11.10M	shares	Annual
Basic weighted average number of shares	`WeightedAverageNumberOfSharesOutstandingBasic`	13.07M	shares	Annual
Diluted weighted average number of shares	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.10M	shares	Annual
Diluted weighted average number of shares	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.07M	shares	Annual

Cash Flow Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net income/(loss)	`NetIncomeLoss`	$-1.89M	USD	3 Qtrs
Net income/(loss)	`NetIncomeLoss`	$-2.78M	USD	Annual
Net income/(loss)	`NetIncomeLoss`	$-814.08K	USD	Annual
Depreciation and amortization	`Depreciation`	$1.36M	USD	Annual
Depreciation and amortization	`Depreciation`	$166.28K	USD	Annual
Provision for doubtful debts/ (written back), net	`PremiumsReceivableAllowanceForDoubtfulAccountsRecoveries`	$410.71K	USD	Annual
Provision for doubtful debts/ (written back), net	`PremiumsReceivableAllowanceForDoubtfulAccountsRecoveries`	-	USD	Annual
Accrued interest on convertible notes	`InterestAndDebtExpense`	$125.00K	USD	Annual
Accrued interest on convertible notes	`InterestAndDebtExpense`	-	USD	Annual
Change due to estimate correction	`ChangeDueToEstimateCorrection2`	-	USD	Annual
Change due to estimate correction	`ChangeDueToEstimateCorrection2`	$410.82K	USD	Annual
Stock, option, restricted stock unit and warrant expense	`StockOptionPlanExpense`	$1.46M	USD	Annual
Stock, option, restricted stock unit and warrant expense	`StockOptionPlanExpense`	$141.91K	USD	Annual
Deferred income taxes, net	`DeferredIncomeTaxExpenseBenefit`	-	USD	Annual
Deferred income taxes, net	`DeferredIncomeTaxExpenseBenefit`	$-3.49M	USD	Annual
Foreign exchange translation adjustment	`ForeignCurrencyTransactionGainLossBeforeTax`	$-7.43K	USD	Annual
Foreign exchange translation adjustment	`ForeignCurrencyTransactionGainLossBeforeTax`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsAndNotesReceivable`	$-3.19M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsAndNotesReceivable`	$-3.55M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-169.55K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-198.43K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.60M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-89.59K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.70M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.90M	USD	Annual
Purchase of intangible and fixed assets	`IncreaseDecreaseInOtherOperatingLiabilities`	$-3.69M	USD	Annual
Purchase of intangible and fixed assets	`IncreaseDecreaseInOtherOperatingLiabilities`	$-70.78K	USD	Annual
Acquisition consideration payable	`NoncashOrPartNoncashAcquisitionPayablesAssumed1`	$2.90M	USD	Annual
Acquisition consideration payable	`NoncashOrPartNoncashAcquisitionPayablesAssumed1`	$1.77M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.59M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.84M	USD	Annual
Proceeds from loan funds	`ProceedsFromConvertibleDebt`	$3.79M	USD	Annual
Proceeds from loan funds	`ProceedsFromConvertibleDebt`	$6.24M	USD	Annual
Non-Controlling Interests net income	`IncomeLossIncludingPortionAttributableToNoncontrollingInterest`	$3.38K	USD	Annual
Non-Controlling Interests net income	`IncomeLossIncludingPortionAttributableToNoncontrollingInterest`	-	USD	Annual
Additional stock issued	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$-5.00M	USD	Annual
Additional stock issued	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.24M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.80M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-498.15K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$496.98K	USD	Annual
Cash and cash equivalents as at beginning of the year	`Cash`	$1.38M	USD	Point-in-time
Cash and cash equivalents as at beginning of the year	`Cash`	$1.88M	USD	Point-in-time
Cash and cash equivalents as at beginning of the year	`Cash`	$1.38M	USD	Point-in-time
Cash at the end of the year	`Cash`	$1.38M	USD	Point-in-time
Cash at the end of the year	`Cash`	$1.88M	USD	Point-in-time
Cash at the end of the year	`Cash`	$1.38M	USD	Point-in-time
Cash paid during the period for Interest	`InterestPaid`	$238.47K	USD	Annual
Cash paid during the period for Interest	`InterestPaid`	$362.79K	USD	Annual
Cash paid during the period for Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for Income taxes	`IncomeTaxesPaid`	-	USD	Annual

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Begnning Balance, Amount	`StockholdersEquity`	$972.86K	USD	Point-in-time
Begnning Balance, Amount	`StockholdersEquity`	$258.53K	USD	Point-in-time
Begnning Balance, Amount	`StockholdersEquity`	$11.66M	USD	Point-in-time
Common stock issued- amount	`StockIssuedDuringPeriodValueIssuedForServices`	$3.00M	USD	Annual
Conversion of notes into preferred shares - amount	`ConversionOfNotesIntoPreferredSharesAmount`	$5.12M	USD	Annual
Conversion of warrants into common shares - amiunt	`ConversionOfWarrantsIntoCommonSharesAmiunt`	$2.00M	USD	Annual
Issuance of capital for services - amount	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$55.12K	USD	3 Qtrs
Issuance of capital for board services -amount	`IssuanceOfCapitalForBoardServicesValue`	$2.04K	USD	3 Qtrs
Recapitalization - amount	`AdjustmentsToAdditionalPaidInCapitalStockSplit`	$-22.64K	USD	3 Qtrs
Issuance of shares for acquisition - amount	`BusinessCombinationConsiderationTransferred1`	$2.61M	USD	Annual
Issuance of shares for acquisition - amount	`BusinessCombinationConsiderationTransferred1`	$1.00M	USD	3 Qtrs
Stock, Option, RSU and Warrant Expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$141.91K	USD	3 Qtrs
Stock, Option, RSU and Warrant Expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.46M	USD	Annual
Non-Controlling Interests Net Income	`IncomeLossIncludingPortionAttributableToNoncontrollingInterest`	$3.38K	USD	Annual
Non-Controlling Interests Net Income	`IncomeLossIncludingPortionAttributableToNoncontrollingInterest`	-	USD	Annual
Accumulated other comprehensive income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-7.43K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.89M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.78M	USD	Annual
Net loss	`NetIncomeLoss`	$-814.08K	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$972.86K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$258.53K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$11.66M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.